World

Sinopharm's COVID booster reverses antibody decline, enhances cell-based responses: study

The findings, yet to undergo peer review, come as China starts to give a third COVID-19 shot to higher risk members of the population, as concerns grow that waning antibody levels over time could weaken protection against the virus.Sinopharm's COVID booster reverses antibody decline, enhances cell-based responses: study
A healthcare worker shows a dose of Sinopharm vaccine against the coronavirus disease (COVID-19) during a mass vaccination program for foreigners in Jakarta, Indonesia, August 24, 2021. Reuters
bookmark
Reuters
Published at : September 17, 2021
Updated at : September 17, 2021 18:21
Beijing

Top